Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane [6]

Eye

Volumn 21, Issue 11, 2007, Pages 1433-1434

  Ruys, J ^a   De Laey, J J ^a   Vanderhaeghen, Y ^a   Van Aken, E H ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; BEVACIZUMAB;

ADULT; CASE REPORT; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; JUXTAFOVEAL RETINA TELANGIECTASIA; LETTER; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; RETINA MACULA EDEMA; SCAR FORMATION; SUBRETINAL NEOVASCULARIZATION; TELANGIECTASIA; VISUAL ACUITY; VISUAL DISORDER;

EID: 35948985139     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702946     Document Type: Letter

References (4)

1. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993; 100: 1536-1546.
2. Gass JDM. Histological study of presumed parafoveal telangiectasia. Retina 2000; 20: 226-227.
3. Bhisitkul RB. Vascular endothelial growth factor biology: Clinical implications for ocular treatments. Br J Ophthalmol 2006; 90 1542-1547.
4. Potter MJ, Szabo SM, Chan EY, Morris AH. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 2002; 133: 149-151.